View:
Download DOC
Download PDF
SEC FORM 3/A SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Coughlin Terrance J
(Last) (First) (Middle)
C/O ENDO INTERNATIONAL PLC
FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD
(Street)
BALLSBRIDGE, DUBLIN L2 0
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/01/2016 		3. Issuer Name and Ticker or Trading Symbol
Endo International plc [ ENDP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Operating Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
11/08/2016
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1) 120,337 D
2015 Stock Incentive Plan Restricted Stock Units (RSU)(2) 3,639 D
2015 Stock Incentive Plan Restricted Stock Units (RSU)(3) 4,000 D
2015 Stock Incentive Plan Restricted Stock Units (RSU)(4) 5,159 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
2015 Stock Incentive Plan Stock Options (NQ)(5) (5) 09/28/2025 Ordinary Shares 17,974 61.82 D
2015 Stock Incentive Plan Stock Options (NQ)(6) (6) 02/23/2026 Ordinary Shares 17,401 50.22 D
Explanation of Responses:
1. Represents Mr. Coughlin's ordinary share ownership on November 1, 2016. The original Form 3 incorrectly reported 119,837 ordinary shares.
2. 4,852 restricted stock units (RSUs) were granted to Mr. Coughlin on September 28, 2015 under the 2015 Stock Incentive Plan. These RSUs generally vest 25% per year on each of September 28, 2016, September 28, 2017, September 28, 2018 and September 28, 2019. Upon vesting, we consider the underlying RSUs to be expired. As of November 1, 2016 (the date of Mr. Coughlin's appointment as an executive officer of Endo International plc), 1,213 RSUs were vested and released.
3. 6,000 RSUs were granted to Mr. Coughlin on September 28, 2015 under the 2015 Stock Incentive Plan. These RSUs generally vest 33 1/3% per year on each of September 28, 2016, September 28, 2017, and September 28, 2018. Upon vesting, we consider the underlying RSUs to be expired. As of November 1, 2016, 2,000 RSUs were vested and released. The original Form 3 incorrectly reported: (a) these RSUs to have a four-year vesting schedule, (b) that 1,500 of these RSUs were vested and released as of November 1, 2016, and (c) that 4,500 of these RSUs were beneficially owned as of November 1, 2016.
4. These RSUs were granted to Mr. Coughlin on February 23, 2016 under the 2015 Stock Incentive Plan. They vest 25% annually at each future grant date anniversary through February 23, 2020. Upon vesting, we consider the underlying RSUs to be expired.
5. These non-qualified stock options were granted to Mr. Coughlin on September 28, 2015 under the 2015 Stock Incentive Plan. These non-qualified stock options generally vest 25% per year on each of September 28, 2016, September 28, 2017, September 28, 2018 and September 28, 2019. As of November 1, 2016, 4,494 non-qualified stock options were vested.
6. These non-qualified stock options were granted to Mr. Coughlin on February 23, 2016 under the 2015 Stock Incentive Plan. These stock options vest 25% per year on each grant date anniversary through February 23, 2020.
Remarks:
On November 1, 2016, Endo International plc appointed Mr. Coughlin as Executive Vice President and Chief Operating Officer, effective November 1, 2016. These securities represent the amounts owned by Mr. Coughlin as of November 1, 2016, the date of his appointment. This Form 3/A amends and replaces in its entirety the Form 3 filed by the Reporting Person on November 8, 2016. This Form 3/A corrects an administrative error in the original Form 3 as described in explanations 1 and 3 above.
s/ Matthew J. Maletta, by power of attorney 10/02/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS

	Know all by these present that the undersigned hereby makes, constitutes and
appoints Matthew J. Maletta, Orla Dunlea, Daniel A. Rudio, Frank Schuenemann,
Mark Wicoff and Sarah Beck as the undersigned's true and lawful
attorneys-in-fact, with full power and authority as hereinafter described on
behalf of and in the name, place and stead of each of the undersigned to:

(1)	prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including
any amendments thereto) with respect to the securities of Endo International
plc, an Irish public limited company (the "Company"), with the United States
Securities and Exchange Commission, any national securities exchanges and the
Company, as considered necessary or advisable under Section 16(a) of the
Securities Exchange Act of 1934 and the rules and regulations promulgated
thereunder, as amended from time to time (the "Exchange Act");

(2)	seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information on transactions in the Company's securities from any third
party, including brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any such
information to the undersigned and approves and ratifies any such release of
information; and

(3)	perform any and all other acts which in the discretion of such
attorney-in-fact are necessary or desirable for and on behalf of the undersigned
in connection with the foregoing.

The undersigned acknowledges that:

(1)	this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in their discretion on information provided to such
attorney-in-fact without independent verification of such information;

(2)	any documents prepared and/or executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney will be in such form and will
contain such information and disclosure as such attorney-in-fact, in his or her
discretion, deems necessary or desirable;

(3)	neither the Company nor such attorney-in-fact assumes (i) any liability for
the undersigned's responsibility to comply with the requirement of the Exchange
Act, (ii) any liability of the undersigned for any failure to comply with such
requirements, or (iii) any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act; and

(4)	this Power of Attorney does not relieve the undersigned from responsibility
for compliance with the undersigned's obligations under the Exchange Act,
including without limitation the reporting requirements under Section 16 of the
Exchange Act.

The undersigned hereby gives and grants the foregoing attorney-in-fact full
power and authority to do and perform all and every act and thing whatsoever
requisite, necessary or appropriate to be done in and about the foregoing
matters as fully to all intents and purposes as the undersigned might or could
do if present, hereby ratifying all that such attorney-in-fact of, for and on
behalf of the undersigned, shall lawfully do or cause to be done by virtue of
this Limited Power of Attorney.

	This Power of Attorney shall remain in full force and effect with respect to
each undersigned until revoked by such undersigned in a signed writing delivered
to such attorney-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 4th day of November 2016.

SIGNATURE					TITLE


/S/ Terrance J. Coughlin		Executive Vice President and
NAME:  Terrance J. Coughlin		Chief Operating Officer



STATE OF New York:
COUNTY OF Rockland:


On this 4th day of November 2016, the above-named individual personally appeared
before me, and acknowledged that he executed the foregoing instrument for the
purposes therein contained.

IN WITNESS WHEREOF, I have hereunto set my hand and official seal.


/S/ Marian E. Gustafson
Notary Public

Marian E. Gustafson
Notary Public - State of New York
No. 01GU4719491
Qualified in Rockland County
My Commission Expires on 4/30/2018